Clinical Trials Directory

Trials / Unknown

UnknownNCT03746925

Comparing Short-term Outcomes After Direct Anterior and SuperPATH Hip Arthroplasty Approaches

Randomized Control Trial Comparing Short-term Outcomes After Direct Anterior and SuperPATH Approaches

Status
Unknown
Phase
N/A
Study type
Interventional
Enrollment
100 (estimated)
Sponsor
Ottawa Hospital Research Institute · Academic / Other
Sex
All
Age
18 Years – 80 Years
Healthy volunteers
Not accepted

Summary

This study involves comparing the outcomes after using the Direct Anterior Approach (DAA) and the Supercapsular Percutaneously Assisted Total Hip (SuperPATH) approach. These are two approaches to hip replacement that both replace hips without cutting any muscles. DAA approach has been used for many years, but it has a high learning curve and can be difficult for doctors to use, it is however linked with fewer complications when performed by an experienced doctor. SuperPATH is a newer technique which has been shown in studies to be adopted with less complications even during the learning phase. It also shows cost-saving results, showing a reduced length of stay for patients and better 30-day readmission rates. There is pressure on surgeons, from both patients and administration to use techniques that spare tissue, offer early functionality without compromising long-term outcomes. The SuperPATH can meet this benchmark but uptake has been slow, the investigators believe that it is due to the learning curve shown by this approach. The senior surgeon at The Ottawa Hospital is experienced in both techniques, using a trial the investigators can compare the two techniques and help encourage surgeons to change to a procedure that has demonstrated a low complication profile.

Conditions

Interventions

TypeNameDescription
PROCEDUREDirect Anterior Approach (DAA)Direct Anterior Approach surgery to replace the hip.
PROCEDURESuperPATHSuperPATH approach surgery to replace the hip.

Timeline

Start date
2019-09-07
Primary completion
2023-01-07
Completion
2023-04-07
First posted
2018-11-20
Last updated
2022-08-08

Locations

1 site across 1 country: Canada

Source: ClinicalTrials.gov record NCT03746925. Inclusion in this directory is not an endorsement.